Results
724 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 50 | Baugher Joshua ScottChief Financial Officer |  AGXARGAN INCOpen-market sale | SELL | $363K 600 sh | Apr 20, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 50 | Baugher Joshua ScottChief Financial Officer | AGXARGAN INC Open-market sale | SELL | $363K 600 sh | Apr 20, 2026 |
| 52 | Earl JohnPresident | NAKeystone Private Income Fund Open-market purchase | BUY | $3.00M 30.6K sh | Apr 17, 2026 traded Apr 1, 2026 |
| 55 | Partners Group Finance (USD) AGAffiliate of the Adviser | NAPARTNERS GROUP NEXT GENERATION INFRASTRUCTURE, LLC Open-market sale | SELL | $132.59M 72.06M sh | Apr 15, 2026 traded Apr 1, 2026 |
| 52 | Mulligan John JDirector |  CAGCONAGRA BRANDS INC.Open-market purchase | BUY | $250K 17.5K sh | Apr 15, 2026 traded Apr 14, 2026 |
| 51 | VisionWave Holdings, Inc.Director |  SVRESaverOne 2014 Ltd.Open-market purchase | BUY | $8.63B 2.50B sh | Apr 15, 2026 traded Apr 9, 2026 |
| 51 | VisionWave Holdings, Inc.Director | SVRESaverOne 2014 Ltd. Open-market purchase | BUY | $148.26M 49.42M sh | Apr 15, 2026 traded Mar 30, 2026 |
| 51 | VisionWave Holdings, Inc.Director | SVRESaverOne 2014 Ltd. Open-market purchase | BUY | $2.12B 706.58M sh | Apr 15, 2026 traded Apr 2, 2026 |
| 60 | George GregoryDirector, 10% Owner |  MESOMESOBLAST LTDOpen-market purchase | BUY | $5.68M 4.00M sh | Apr 13, 2026 traded Apr 4, 2026 |
| 51 | Wahrhaftig Marcos Eduardo FaracoExecutive Vice President |  GGBGERDAU S.A.Open-market sale | SELL | $50K 12.4K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 56 | George GregoryDirector, 10% Owner | MESOMESOBLAST LTD Open-market purchase | BUY | $5.68M 4.00M sh | Apr 10, 2026 traded Apr 4, 2026 |
| 51 | Page JustineDirector |  AVGOBroadcom Inc.Open-market sale | SELL | $712K 2,018 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 51 | Velaga S. RamPresident, ISG | AVGOBroadcom Inc. Open-market sale | SELL | $6.08M 17.3K sh | Apr 10, 2026 traded Apr 9, 2026 |
| 50 | Kawwas Charlie BPresident, SSG | AVGOBroadcom Inc. Open-market sale | SELL | $3.45M 10.0K sh | Apr 10, 2026 traded Apr 8, 2026 |
| 67 |  Josh GottheimerDJoint |  MSFTMICROSOFT CORPPurchase | BUY | $500K – $1.00M | Apr 8, 2026 traded Mar 25, 2026 |
| 61 | Josh GottheimerDJoint | MSFTMICROSOFT CORP Purchase | BUY | $50K – $100K | Apr 8, 2026 traded Mar 25, 2026 |
| 55 |  Gilbert Ray Cisneros, Jr.DSelf | MSFTMICROSOFT CORP Purchase | BUY | $15K – $50K | Apr 7, 2026 traded Mar 13, 2026 |
| 50 | Thompson Amanda JChief People Officer |  GAPGAP INCOpen-market sale | SELL | $583K 23.2K sh | Apr 7, 2026 traded Apr 6, 2026 |
| 69 | Rowley RussellInvestment Committee | NAPrincipal Private Credit Fund Open-market purchase | BUY | $60K 5,803 sh | Apr 6, 2026 traded Jul 31, 2025 |
| 64 | Miazga BrianInvestment Committee | NAPrincipal Private Credit Fund Open-market purchase | BUY | $108K 10.4K sh | Apr 6, 2026 traded Aug 7, 2025 |
| 61 | Urbates JamesInvestment Committee | NAPrincipal Private Credit Fund Open-market purchase | BUY | $46K 4,433 sh | Apr 6, 2026 traded Jul 23, 2025 |
| 52 | Urbates JamesInvestment Committee | NAPrincipal Private Credit Fund Open-market purchase | BUY | $47K 4,535 sh | Apr 6, 2026 traded Mar 18, 2026 |
| 51 |  Kelly MorrisonDSelf | Andersen Corporation Partial sale | SELL | $250K – $500K | Apr 2, 2026 traded Mar 15, 2025 |
| 51 | Kelly MorrisonDSelf | Andersen Corporation Partial sale | SELL | $500K – $1.00M | Apr 2, 2026 traded Jan 20, 2025 |
| 51 | Kelly MorrisonDSelf | Andersen Corporation Partial sale | SELL | $250K – $500K | Apr 2, 2026 traded Jun 15, 2025 |
| 51 | Kelly MorrisonDSelf | Andersen Corporation Partial sale | SELL | $250K – $500K | Apr 2, 2026 traded Jan 20, 2026 |
| 50 | Skaff Michael C10% Owner |  VVOSVivos Therapeutics, Inc.Open-market purchase | BUY | $2.39M 1.78M sh | Apr 2, 2026 traded Mar 31, 2026 |
| 50 | Skaff Michael C10% Owner | VVOSVivos Therapeutics, Inc. Open-market purchase | BUY | $2.39M 1.78M sh | Apr 2, 2026 traded Mar 31, 2026 |
| 50 | Skaff Michael C10% Owner | VVOSVivos Therapeutics, Inc. Open-market purchase | BUY | $1.40M 1.04M sh | Apr 2, 2026 traded Mar 31, 2026 |
| 51 | Zagari RaffaeleDirector |  SBLKStar Bulk Carriers Corp.Open-market sale | SELL | $2.62B 11.5K sh | Apr 1, 2026 traded Mar 31, 2026 |
| 51 | Carter Charles EdwardChief Regional Officer: Amer. |  SBSWSibanye Stillwater LtdOpen-market purchase | BUY | $114K 10.0K sh | Mar 31, 2026 traded Mar 30, 2026 |
| 50 | Weaver Robert S.EVP, Government Relations |  NXSTNEXSTAR MEDIA GROUP, INC.Open-market sale | SELL | $399K 1,872 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 50 | Morgan RachelEVP General Counsel | NXSTNEXSTAR MEDIA GROUP, INC. Open-market sale | SELL | $668K 3,127 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 57 | Schimmelpennink Evert B.Director, President, CEO and Secretary |  LENZLENZ Therapeutics, Inc.Open-market purchase | BUY | $251K 28.1K sh | Mar 30, 2026 traded Mar 27, 2026 |
| 52 | Arima AnastasiosChief Executive Officer |  IPXIPERIONX LtdOpen-market purchase | BUY | $300K 12.8K sh | Mar 30, 2026 traded Mar 27, 2026 |
| 51 | George Jeffrey P.Director | LENZLENZ Therapeutics, Inc. Open-market purchase | BUY | $50K 5,592 sh | Mar 30, 2026 traded Mar 27, 2026 |
| 50 | Chevallard Daniel R.Chief Financial Officer | LENZLENZ Therapeutics, Inc. Open-market purchase | BUY | $64K 7,500 sh | Mar 30, 2026 traded Mar 27, 2026 |
| 50 | Jansen John MDirector |  OKLOOklo Inc.Open-market sale | SELL | $541K 10.5K sh | Mar 30, 2026 traded Mar 27, 2026 |
| 66 | McHaffa Evan S.EVP/Chief Credit Officer |  FMBMF&M BANK CORPOpen-market purchase | BUY | $20K 650 sh | Mar 27, 2026 traded Mar 19, 2026 |
| 54 | Zimmer DanaSee Remarks | NXSTNEXSTAR MEDIA GROUP, INC. Open-market sale | SELL | $994K 4,409 sh | Mar 26, 2026 traded Mar 24, 2026 |
| 51 | Thompson Elizabeth H.Z.EVP, Head of Research & Dev |  ACADACADIA PHARMACEUTICALS INCOpen-market sale | SELL | $74K 3,435 sh | Mar 26, 2026 traded Mar 25, 2026 |